XIFAXAN 200mg Rx
Generic Name and Formulations:
Rifaximin 200mg; tabs.
Valeant Pharmaceuticals, Inc
Indications for XIFAXAN 200mg:
Travelers' diarrhea due to noninvasive E. coli. Limitations of use: not for use if diarrhea is accompanied by fever or blood in stool, or if causative agent other than E. coli may be suspected (eg, C. jejuni, Shigella spp., Salmonella spp.).
200mg 3 times daily for 3 days.
Discontinue and reevaluate if diarrhea worsens or persists >24–48hrs. Not for treating systemic infections. Severe hepatic impairment (Child-Pugh C). Elderly. Pregnancy. Nursing mothers.
Potentiated by P-gp inhibitors (eg, cyclosporine); caution. Monitor INR and PT with warfarin; dose adjustment may be needed.
Flatulence, headache, abdominal pain, rectal tenesmus, defecation urgency, nausea.
Endocrinology Advisor Articles
- GLP-1 Agonists Superior to DPP-4 Inhibitors for Reducing HbA1c, Weight in T2D
- Effect of HbA1c and Perioperative Glucose on Postoperative Mortality
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Once-Daily Oral Contraceptive for Men Shows Promise
- Reducing Total Daily Insulin Dose in T2D: 3-Meal vs 6-Meal Diet
- American College of Physicians Releases 4 Guidelines for HbA1c Targets in T2D
- Dyslipidemia Drug Indications
- No Difference in Weight Loss Outcomes With Low-Fat vs Low-Carbohydrate Diet
- Damaging Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture
- Gastric Bypass Surgery Linked to Increased Risk for Nonvertebral Fractures
- Effect of High Androgen Levels on Cardiovascular Risk in Postmenopausal Women
- Fertility in Women Negatively Affected by Asthma Medications
- Glucocorticoid Use in COPD Does Not Increase Fracture Risk
- Drug Copayments Often Cost More Than Prescription Drugs
- Closed-Loop Insulin Delivery Offers Best Outcomes for Pregnant Women With T1D